Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/11/2978268/0/en/Based-on-Recent-FDA-Feedback-RAPT-Therapeutics-Stops-Zelnecirnon-Program-Following-Clinical-Hold-Due-to-Single-SAE-of-Severe-Liver-Injury.html

GLOBENEWSWIRE
11 Nov 2024